6533b82afe1ef96bd128c066

RESEARCH PRODUCT

1308 Evaluating the prognostic role of serum extracellular domain (ECD) of HER-2/neu (s-HER2) in patients (PTS) with metastatic (M) breast cancer (BC): results of an observational study

L. Di NotoLaura PalmeriM. VaglicaSergio PalmeriA. MangiameliA MarcheseAlberto Bongiovanni

subject

OncologyCancer Researchmedicine.medical_specialtybusiness.industrymedicine.diseaseDomain (software engineering)Breast cancerOncologyHer 2 neuInternal medicineExtracellularMedicineObservational studyIn patientbusinesshttps://doi.org/10.1016/s1359-6349(09)70481-1